Biotech Pentixapharm Announces FDA Clearance of IND for Phase 3 PANDA Study of First-in-Class Cardiovascular Diagnostic Program October 6, 2026
Biotech HERVolution Therapeutics Demonstrates Preclinical Proof-of-Concept for Insulin Sensitization Immune Therapy in Metabolic Disease and Announces Exclusive License Agreement with the University of Copenhagen October 5, 2026
Biotech New Case Series on Umbilical Tissue in Plantar Fascia Applications Demonstrates Clinical Reproducibility October 4, 2026
Biotech Hyundai Bioscience USA offers Free Drug Supply and Funding for Clinical Trials to WHO October 2, 2026
Biotech IMAAVY® (nipocalimab-aahu) demonstrates durable hemoglobin response and rapid onset of effect in pivotal Phase 2/3 study in warm autoimmune hemolytic anemia (wAIHA), an autoantibody-driven disease with no FDA-approved therapies September 30, 2026
Biotech Volta Labs Brings the Complete Twist Hybrid Capture Portfolio to Callisto™ with Launch of Twist Fast Hyb September 29, 2026
Biotech The Galien Foundation Honours Leaders in Life Sciences Innovation with the 2026 Prix Galien UK Awards September 28, 2026
Biotech Promising First-in-Patient Results for ACOU085 (INN: Bimokalner) in Cisplatin-Induced Ototoxicity September 27, 2026